Major Salivary Gland Neoplasm — Trials

Major Salivary Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05408845	Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers	recruiting	Phase 2	146	NRG OncologyOTHER	1	Aug 17, 2026	clinicaltrials
NCT02834013	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	active not recruiting	Phase 2	798	National Cancer Institute (NCI)NIH	2	Jun 17, 2026	clinicaltrials
NCT04895735	MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer	active not recruiting	Phase 2	45	Mayo ClinicOTHER	1	Jun 4, 2026	clinicaltrials
NCT06054178

Data updated 22 days agoSource updated Aug 17, 2026source: clinicaltrials